Recently Visited

{{scheme.chgp}}%

Premium

{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}

{{scheme.scoreText}} | Score {{scheme.score}}

Most Searched

{{scheme.chgp}}%

Premium

{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}

{{scheme.scoreText}} | Score {{scheme.score}}

No Matches Found

ImmunoGen, Inc.

Who are in the management team of ImmunoGen, Inc.?

As of March 2022, the management team of ImmunoGen, Inc. includes Mr. Stephen McCluski (Independent Chairman), Mr. Mark Enyedy (President and CEO), and several independent directors: Mr. Stuart Arbuckle, Dr. Mark Goldberg, Mr. Dean Mitchell, Ms. Kristine Peterson, and Mr. Richard Wallace. They oversee the company's strategic direction and operations.

Jun 22 2025 10:00 PM IST

Share Via

{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)

{{ra.stock_return.chgp}}%

{{ra.sensex_return.chgp}}%

Change%

Figures in Rs cr

How big is ImmunoGen, Inc.?

As of September 2023, ImmunoGen, Inc. has an unavailable market capitalization. The company reported net sales of $287.61 million and a net loss of $73.52 million for the latest four quarters, with shareholder's funds of $155.83 million and total assets of $348.94 million as of December 2022.

Jun 22 2025 05:29 PM IST

Share Via

${{list.post_title_sep}}$

Share Via

Our weekly and monthly stock recommendations are here

Stock of the Week

Industry

Market Cap

Date of Entry

Entry Price

Target Price

{{sm.target_price }} ({{sm.performance_target }}%)

Holding Duration

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Week

Stock of the Month

{{sm.comp_name}} price as on {{sm.todays_date}}

₹{{sm.price_as_on}} ({{sm.performance}}%)

Industry

Market Cap

Date of Entry

Entry Price

Last 1 Year Return

{{sm.performance_1y}}%

Upgrade to Unlock the Latest Stock of the Month

ImmunoGen, Inc.

How big is ImmunoGen, Inc.?

{{list.post_title}}

{{list.post_title}}